Sonoma Pharmaceuticals (SNOA) Amortizatization of Intangibles (2010 - 2011)
Sonoma Pharmaceuticals' (SNOA) quarterly Amortizatization of Intangibles came in at $156000.0 in Q4 2011, down 37.6% year-on-year from $250000.0 in Q4 2010, and little changed quarter-over-quarter from $156000.0 in Q3 2011.
Sonoma Pharmaceuticals (SNOA) Amortizatization of Intangibles (2010 - 2011) Analysis & Trends
Sonoma Pharmaceuticals' Amortizatization of Intangibles history runs 2 years deep, the most recent figure standing at $156000.0 for Q4 2011.
- On a quarterly basis, Amortizatization of Intangibles fell 37.6% year-over-year to $156000.0 in Q4 2011; TTM through Mar 2012 was $1.2 million, a 66.67% increase from a year earlier, with the FY2012 full-year figure at $1.2 million, up 66.67% from the prior year.
- Amortizatization of Intangibles steadied at $156000.0 in Q4 2011 per SNOA's latest filing, from $156000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $938000.0 in Q2 2011 and bottomed at $156000.0 in Q3 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 1.30 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Sonoma Pharmaceuticals | 1.95 Mn | -445,560.06 | 2.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | 156,000.00 |
| Dec 31, 2011 | 156,000.00 |
| Sep 30, 2011 | 156,000.00 |
| Sep 30, 2011 | 156,000.00 |
| Jun 30, 2011 | 938,000.00 |
| Jun 30, 2011 | 938,000.00 |
| Dec 31, 2010 | 250,000.00 |
| Dec 31, 2010 | 250,000.00 |
| Jun 30, 2010 | 500,000.00 |
| Jun 30, 2010 | 500,000.00 |